Peter Grogg
Direttore/Membro del Consiglio presso BACHEM HOLDING AG
Patrimonio netto: 3 782 M $ in data 30/04/2024
Profilo
Il Dr. Peter Grogg è presidente della Ingro Finanz AG. Fa parte del Consiglio di amministrazione di Kenta Biotech AG e Bachem Holding AG. Il Dr. Grogg è stato precedentemente impiegato come Vice Presidente del Consiglio di Sorveglianza di Sunstar-Holding AG, Vice Presidente di Dottikon Es Holding AG, Amministratore Delegato di Bachem AG, Partner di Fox-Chemicals GmbH, Principale di Ciba Holding AG, Presidente di MFC Beteiligungs AG e Presidente di Pevion Biotech AG. È stato anche membro del consiglio di amministrazione di Berna Biotech AG, GABA AG e Polyphor AG.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
BACHEM HOLDING AG CLASS B
51.94% | 12/05/2023 | 38 957 455 ( 51.94% ) | 3 405 M $ | 30/04/2024 |
DOTTIKON ES HOLDING AG
7.00% | 31/03/2023 | 979 936 ( 7.00% ) | 256 M $ | 30/04/2024 |
BURKHALTER HOLDING AG
10.39% | 31/12/2022 | 1 103 787 ( 10.39% ) | 121 M $ | 30/04/2024 |
Posizioni attive di Peter Grogg
Società | Posizione | Inizio |
---|---|---|
BACHEM HOLDING AG | Direttore/Membro del Consiglio | - |
Kenta Biotech AG
Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland. | Direttore/Membro del Consiglio | - |
Ingro Finanz AG
Ingro Finanz AG Financial ConglomeratesFinance Ingro Finanz AG provides investment services. The company is based in Bubendorf, Switzerland. | Presidente | 05/01/2011 |
Precedenti posizioni note di Peter Grogg
Società | Posizione | Fine |
---|---|---|
DOTTIKON ES HOLDING AG | Direttore/Membro del Consiglio | 06/07/2012 |
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Amministratore Delegato | 01/01/2002 |
MFC Beteiligungs AG | Presidente | - |
Sunstar-Holding AG
Sunstar-Holding AG Hotels/Resorts/Cruise linesConsumer Services Sunstar-Holding AG engages in the operation of holiday hotels. The company was founded by Fritz Buser and Ernst Rieder on March 14, 1969 and is headquartered in Liestal, Switzerland. | Direttore/Membro del Consiglio | - |
Fox-Chemicals GmbH | Corporate Officer/Principal | - |
Formazione di Peter Grogg
University of Basel | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
SPEXIS AG | Health Technology |
BACHEM HOLDING AG | Health Technology |
DOTTIKON ES HOLDING AG | Process Industries |
Aziende private | 10 |
---|---|
Berna Biotech AG
Berna Biotech AG Miscellaneous Commercial ServicesCommercial Services Berna Biotech AG produced and developed immunobiological preparations. It offered respiratory, hepatitis B, pediatric, veterinary and travel vaccines. The company was founded in 1898 and was headquartered in Bern, Switzerland | Commercial Services |
GABA AG
GABA AG Medical DistributorsDistribution Services GABA AG manufactures oral care products. Its brands include aronal, elmex and meridol. GABA develops its develops products in the field of dentistry, molecular biology, ergonomy, and others. The company was founded in 1917 by Dr. Hermann Geiger and is headquartered in Therwil, Switzerland. | Distribution Services |
Pevion Biotech AG
Pevion Biotech AG Pharmaceuticals: MajorHealth Technology Pevion Biotech AG develops efficient and safe vaccines based on proprietary technology. The firm provides preclinical and clinical development of prophylactic/therapeutic vaccines based on its virosome-based technology platform. The company was founded in 2002 and is headquartered in Ittigen, Switzerland. | Health Technology |
Kenta Biotech AG
Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland. | Health Technology |
Ciba Holding AG
Ciba Holding AG Chemicals: Major DiversifiedProcess Industries Ciba Holding AG manufactures and markets chemicals that provide color, performance and care for plastics, coatings, textile, paper, home & personal care and other products. The firm provides services to the plastic, rubber, adhesives lubricant, home and personal care, coatings, graphic arts, electronic, detergents and hygiene industries. It operates through four segments Plastic Additives, Coating Effects, Water & Paper Treatment and Textile Effects. The company has offices in Europe, America and Asia. Ciba Holding was founded on April 24, 1996 and is headquartered in Basel, Switzerland. | Process Industries |
Fox-Chemicals GmbH | |
Ingro Finanz AG
Ingro Finanz AG Financial ConglomeratesFinance Ingro Finanz AG provides investment services. The company is based in Bubendorf, Switzerland. | Finance |
Sunstar-Holding AG
Sunstar-Holding AG Hotels/Resorts/Cruise linesConsumer Services Sunstar-Holding AG engages in the operation of holiday hotels. The company was founded by Fritz Buser and Ernst Rieder on March 14, 1969 and is headquartered in Liestal, Switzerland. | Consumer Services |
MFC Beteiligungs AG | |
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Peter Grogg